![Glynn Wilson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Glynn Wilson
Director/Board Member at
CADRENAL THERAPEUTICS, INC.
Net worth: 571 532 $ as of 2026-05-30
Profile
Dr. Glynn Wilson is a Chief Executive Officer & Director at Caring Brands, Inc. and an Independent Director at Cadrenal Therapeutics, Inc. He is on the Board of Directors at Caring Brands, Inc. and Cadrenal Therapeutics, Inc. Dr. Wilson was previously employed as a Chief Scientific Officer by Bonk, Inc., a Chief Scientific Officer by Auriga Laboratories, Inc. /Old/, a Chairman by TapImmune, Inc., a Chairman by Tapimmune, Inc., a President & Chief Executive Officer by PharmaSpec Corp., a Vice President-Research & Development by PlasmaTech Biopharmaceuticals, Inc., a Chief Scientific Officer by Tacora Corp, a Head-Worldwide Drug Delivery by Smithkline Beecham Plc, a Research Head-Cell & Molecular Biology by Ciba-Geigy Pharmaceuticals, and a President & Chief Executive Officer by The GW Group.
He received his doctorate degree from The Rockefeller University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
5.5% | 2026-03-26 | 500,000 ( 5.5% ) | 555 000 $ | 2026-05-30 |
| 2025-07-27 | 3,333 ( 0.12% ) | 16 532 $ | 2026-05-30 |
Glynn Wilson active positions
| Companies | Position | Start |
|---|---|---|
| CADRENAL THERAPEUTICS, INC. | Director/Board Member | 2023-01-18 |
Former positions of Glynn Wilson
| Companies | Position | End |
|---|---|---|
| MARKER THERAPEUTICS, INC. | Chief Executive Officer | 2017-09-24 |
Tapimmune, Inc. | Chief Executive Officer | 2017-08-31 |
Auriga Laboratories, Inc. /Old/
 Auriga Laboratories, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Researches and develops pharmaceutical products | President | 2006-03-12 |
PharmaSpec Corp. | President | 1999-12-31 |
| ABEONA THERAPEUTICS INC. | Chief Tech/Sci/R&D Officer | 1997-12-31 |
Training of Glynn Wilson
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
58
1st degree connections
12
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 12 |
|---|---|
Abeona Therapeutics, Inc.
 Abeona Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes cell and gene therapies for life-threatening rare genetic diseases | Health Technology |
Smithkline Beecham Plc
 Smithkline Beecham Plc Pharmaceuticals: OtherHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Marker Therapeutics, Inc.
 Marker Therapeutics, Inc. BiotechnologyHealth Technology Develops and commercializes cell based immune therapeutics and vaccines for cancer treatment | Health Technology |
Auriga Laboratories, Inc. /Old/
Auriga Laboratories, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Researches and develops pharmaceutical products | Health Technology |
Tacora Corp
 Tacora Corp Miscellaneous Commercial ServicesCommercial Services Develops bioresponsive smart polymers | Commercial Services |
The Rockefeller University
 The Rockefeller University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The GW Group | |
PharmaSpec Corp. | |
Ciba-Geigy Pharmaceuticals | |
Safety Shot, Inc.
 Safety Shot, Inc. Pharmaceuticals: OtherHealth Technology Manufactures photocil dietary supplement products | Health Technology |
Tapimmune, Inc. | |
Cadrenal Therapeutics, Inc.
 Cadrenal Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops novel therapy with orphan drug indication | Health Technology |
- Stock Market
- Insiders
- Glynn Wilson
